Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_assertion description "[RUNX3 methylation was also detected in hepatocellular carcinomas (73%, n=48), larynx cancers (62%, n=37), lung cancers (46%, n=24), breast cancers (25%, n=25), prostate cancers (23%, n=44), endometrial cancers (12.5%, n=24), colon cancers (4.9%, n=61) and uterine cervical cancers (2.5%, n=40), showing that RUNX3 methylation is not restricted to gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_assertion evidence source_evidence_literature NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_assertion SIO_000772 14968123 NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_assertion wasDerivedFrom befree-20150227 NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_assertion wasGeneratedBy ECO_0000203 NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP286002.RAwib1hbpjzhRisP-1VokEHEq15Rr9HSdaTSTuOdRVtgs130_provenance.